Core Laboratories Inc.
CLBEnergyNASDAQOil & Gas Equipment & Services
Scan Results
Daily timeframeHeadquartered within the energy sector, Core Laboratories Inc. focuses on Oil & Gas Equipment & Services services and products. Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. At a $454.7M market cap, Core Laboratories Inc. ranks as a small-cap company within energy. It operates through Reservoir Description and Production Enhancement segments.
Market Cap
$454.7M
Beta
1.14
P/E (TTM)
19.06
P/E (Fwd)
14.36
EPS (TTM)
$0.52
EPS (Fwd)
$0.69
ROE
9.0%
ROA
4.5%
Cash
$22.7M
Total Debt
$165.1M
Free CF
$36.0M
52W Change
-41.2%
Annual Financials
Cash vs Debt
Where CLB stands vs its 150-day and 200-day moving averages
As of the October 14, 2026 close, CLB finished 22.21% below its 150-day moving average ($13.06) and 29.20% below its 200-day moving average ($14.35). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CLB overbought or oversold?
At the October 14, 2026 close, CLB's RSI(14) was 40.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $22.7M in cash, though total debt stands at $165.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $36.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 9.0%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $489.7M (2022) to $526.5M (2025).
Core Laboratories Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Core Laboratories Inc. and its sector.